MedImmune will apply the technology to its intranasal FluMist product and its next-generation, refrigerator-stable formulation, CAIV-T. Creation of new vaccine strains is the first step in the influenza
The drug combines the ophthalmic steroid prednisolone acetate with the antibiotic solution prednisolone. Both compounds are commonly prescribed by ophthalmologists, according to Ista Pharmaceuticals, a specialty pharmaceutical company
Abbott and AstraZeneca recently announced that they have formed a collaboration to develop a single pill for lipid management that will combine the active ingredient of Abbott’s fibrate
According to the companies, the research could extend drug discovery efforts into disease targets where traditional discovery technologies have not been successful. During the collaboration, the companies will
The deal sees the Johnson & Johnson unit gain rights to the drug in all terrortories outside of North America, where MGI will retain the rights. Dacogen is
Respiratory syncytial virus (RSV) is a viral infection that can prove fatal to young children and the elderly and for which no preventive treatment by vaccine is currently
The company submitted the new drug application (NDA) in May and the FDA gave priority review status to the application in June. The FDA has set a priority
The acquired assets of Discovery Partners International (DPI) have now become a part of Galapagos’ service division BioFocus DPI. “Galapagos acquired the operational activities of DPI as part
The study is being conducted with several hundred healthy adults in Austria and Singapore using the fully inactivated wild-type H5N1 strain A/Vietnam/1203/2004. Four different antigen concentrations ranging from
All required legal procedures with the relevant Chinese government regulatory and audit procedures have been completed and the title ownership of 100% of Enshi has been passed to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.